CMS Advisory Committee Supports Humanitarian-Device Trial Coverage
This article was originally published in The Gray Sheet
Executive Summary
A Medicare advisory panel voted overwhelmingly Dec. 13 to allow coverage of all humanitarian-use devices in studies that fall under the agency's revised clinical research policy
You may also be interested in...
CMS Research Policy May Deny Coverage For Hundreds Of Device Trials
CMS' proposed Clinical Research Policy has generated widespread concern within the device industry about its potential to restrict Medicare support for clinical trials
CMS Research Policy May Deny Coverage For Hundreds Of Device Trials
CMS' proposed Clinical Research Policy has generated widespread concern within the device industry about its potential to restrict Medicare support for clinical trials
Humanitarian Device Provision Absent From CMS Clinical Research Proposal
CMS' proposed new Medicare coverage policy for clinical research does not include coverage for all humanitarian-use devices in clinical trials, a provision that had been endorsed by an agency advisory panel and medical device companies